Larvol Delta - Diverse-mechanisms-activate-the-PI-3kinasemTOR-pathway-in-melanomas-implications-for-the-use-of-PI-3kinase-inhibitors-to-overcome-resistance-to-inhibitors-of-BRAF-and-MEK

Zelboraf (vemurafenib) - Roche

dactolisib (RTB101) - Adicet Bio

ZSTK474 - Zenyaku Kogyo

http://www.ncbi.nlm.nih.gov/pubmed/33549048

Feb 9, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next